DDInter435 DDInter105
Collagenase clostridium histolyticum is an enzyme produced by the bacterium Clostridium histolyticum. It is beneficial in the breakdown of collagen plaques for the treatment of Dupuytren's contracture and Peyronie's disease. The topical formulation is used for the debridement of necrotic tissue due to burns or chronic ulcers. On July 6, 2020 a combination of injectable bacterial collagenases was approved by the FDA for the treatment of cellulite in adult women. Also known as Qwo, this injection is the first approved injectable treatment for cellulite and was developed by Endo International.
A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily.
Collagenase clostridium histolyticum {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Epoprostenol
Collagenase clostridium histolyticum {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Reteplase
Collagenase clostridium histolyticum may cause a moderate interaction that could exacerbate diseases when taken with Epoprostenol
Collagenase clostridium histolyticum may cause a moderate interaction that could exacerbate diseases when taken with Reteplase